e-learning
resources
Vienna 2003
Wednesday 01.10.2003
Staging and outcome in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Survival quotient: an improved method for expressing severity of lung function abnormality
M. R. Miller, O. F. Pedersen, J. Lloyd, S. Hill, A. Dirksen (Birmingham, Sutton Coldfield, United Kingdom; Aarhus, Copenhagen, Denmark)
Source:
Annual Congress 2003 - Staging and outcome in COPD
Session:
Staging and outcome in COPD
Session type:
Oral Presentation
Number:
3631
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. R. Miller, O. F. Pedersen, J. Lloyd, S. Hill, A. Dirksen (Birmingham, Sutton Coldfield, United Kingdom; Aarhus, Copenhagen, Denmark). Survival quotient: an improved method for expressing severity of lung function abnormality. Eur Respir J 2003; 22: Suppl. 45, 3631
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Prediction of respiratory disease mortality in a population sample is improved by expressing lung function impairment as FEV
1
quotient
Source: Eur Respir J 2005; 26: Suppl. 49, 217s
Year: 2005
Assessment the dependence between nutritional status and functional damage of the lungs as well as prognosis in BODE index in COPD patients
Source: Annual Congress 2013 –COPD treatment
Year: 2013
Accuracy of the calculated estimated postoperative pulmonary function (CEPPF) in lung cancer patients
Source: Annual Congress 2007 - Prognosis and diagnosis of thoracic malignancies
Year: 2007
Age and height dependence of lung clearance index and functional residual capacity
Source: Eur Respir J 2013; 41: 1371-1377
Year: 2013
Screening the general population for lung function abnormalities: yield of respiratory symptoms
Source: Eur Respir J 2002; 20: Suppl. 38, 261s
Year: 2002
How best to measure lung function in animals
Source: Annual Congress 2007 - PG11 - Translation of animal models to human airway disease
Year: 2007
Residual symptoms and lower lung function in patients recovering from SARS-CoV-2 infection
Source: Eur Respir J, 57 (2) 2003002; 10.1183/13993003.03002-2020
Year: 2021
Exercise testing to predict lung cancer surgery outcome: which is better - percentage of predicted VO2 or absolute value?
Source: Eur Respir J 2004; 24: Suppl. 48, 672s
Year: 2004
Predicting IPF outcomes: lung function evaluation by %predicted and z-score
Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia
Year: 2021
Is oscillometry a better metric of respiratory functional capacity compared to conventional pulmonary function tests during the first 6-months post lung transplant?
Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes
Year: 2019
Pulmonary function in sarcoidosis: A review of 85 cases using percentage predicted and lower limit of normal values to determine pattern of pulmonary function deficit
Source: Annual Congress 2011 - Monitoring with lung function tests in airway diseases
Year: 2011
Is lung clearance index a better marker of abnormal airway function than FEV
1
in children with asthma?
Source: Annual Congress 2010 - Phenotypes, mechanisms and diagnosis of asthma in childhood
Year: 2010
Comparison of predictive respiratory function parameters of lung cancer patients having COPD diagnosis with postoperative values and relation with mortality and morbidity
Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients
Year: 2011
Assessing small airway function for early detection of lung function impairment
Source: Eur Respir J, 56 (1) 2001946; 10.1183/13993003.01946-2020
Year: 2020
What is abnormal lung function in an elderly cohort? A comparison of the fixed ratio to the lower limit of normal ratio
Source: Annual Congress 2006 - Highlights of epidemiology of COPD and lung function
Year: 2006
The lung volume reduction surgery: functional outcome with different level of airways obstruction
Source: Annual Congress 2004 - Lung volume reduction surgery and pneumothorax
Year: 2004
Evaluation of asthma control test and correlation with objective measures of lung function and inflammation
Source: Eur Respir J 2007; 30: Suppl. 51, 367s
Year: 2007
Performance scores in patients with suspected lung cancer: reliability of scoring and impact on treatment
Source: Annual Congress 2009 - Epidemiology and management of lung cancer
Year: 2009
Predicting an accelerated lung function decline in smokers: is there a proper threshold?
Source: Eur Respir J 2014; 43: 307-308
Year: 2004
Predicting an accelerated lung function decline in smokers: is there a proper threshold?
Source: Eur Respir J 2014; 43: 308-309
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept